EVOLUT PRO TRANSCATHETER AORTIC VALVE
Report
- Report Number
- 2025587-2021-00715
- Event Type
- Injury
- Date Received
- March 1, 2021
- Date of Event
- December 14, 2020
- Report Date
- March 1, 2021
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: SINGH G, LE V, WIECHMANN RJ, SCHREITER SW. SELF-EXPANDABLE TRANSCATHETER AORTIC VALVE FRAME INFOLDING: AN INCREASINGLY RECOGNIZED COMPLICATION. EJCRIM 2020;7: DOI:10.12890/2020_002100. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A NINETY-THREE-YEAR-OLD MALE PATIENT WITH SYMPTOMATIC SEVERE AORTIC STENOSIS AND AORTIC VALVE CALCIFICATION THAT EXPENDED FROM THE AORTIC ANNULUS TO THE LEFT VENTRICULAR OUTFLOW TRACT (LVOT) WHO UNDERWENT THE IMPLANT OF A MEDTRONIC EVOLUTPRO TRANSCATHETER AORTIC VALVE (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). DURING THE IMPLANT THE VALVE WAS RECAPTURED TWICE. ONCE DEPLOYED, SEVERE PARAVALVULAR LEAK (PVL), INCREASED GRADIENT MEASUREMENTS (MEAN GRADIENT 33 MILLIMETERS OF MERCURY (MMHG) AND AN INFOLD WERE NOTED. SUBSEQUENTLY, A FEW DAYS AFTER THE IMPLANT A BALLOON AORTIC VALVULOPLASTY (BAV) WAS PERFORMED WHICH DECREASED THE GRADIENT TO 11 MMHG AND IMPROVED THE PVL TO MILD. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 288679 | EVOLUT PRO TRANSCATHETER AORTIC VALVE | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | MEDTRONIC HEART VALVES DIVISION | EVOLUTPRO-23 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 93 YR | Required Intervention |